Business ❯ Pharmaceutical Industry

Clinical Research

Drug Development Collaboration Drug Approval Process Funding Innovation Regulatory Affairs Innovative Treatments AstraZeneca Trial Results Novo Nordisk Collaboration Agreements Market Impact

Nektar’s Alopecia Drug Misses Phase 2b Goal as Company Cites Ineligible Patients, Plans Phase 3

Nektar points to eligibility violations inflating the placebo response as it charts a Phase 3 path.

Bristol Myers Delays ADEPT-2 Alzheimer’s Psychosis Readout to 2026 After Site Irregularities

Belite Bio’s Tinlarebant Cuts Stargardt Lesion Growth 36% in Phase 3 Trial

AstraZeneca’s Baxdrostat Lowers 24-Hour Systolic BP by 14 mmHg in Phase 3, AHA Presentation Confirms

Lilly’s Oral GLP-1 Orforglipron Beats Farxiga and Placebo in Two Phase 3 Diabetes Trials

Harvard Team Releases PDGrapher, an AI to Predict Gene and Drug Combos That Reverse Diseased Cell States

Jaypirca Delivers Significant PFS Benefit Over Chemoimmunotherapy in First-Line CLL/SLL

Arvinas’ Vepdegestrant Delays Breast Cancer Progression Longer Than Faslodex